Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Douxfils

Showing results (161-170 of 221) with videos related to

Pageof 23
Sort By:
Clinical Biochemistry|August 29, 2020
High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodiesAntoine Mairesse, Julien Favresse, Christine Eucher, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Evaluation of the DOAC-Stop® Procedure to Overcome the Effect of DOACs on Several Thrombophilia Screening TestsJulien Favresse, Benjamin Lardinois, Lina Sabor, et al.
Annales De Biologie Clinique|October 7, 2020
[Management of the thrombotic risk associated with COVID-19: what is the role of the hemostasis laboratory?]Michael Hardy, Jonathan Douxfils, Jean-Michel Dogné, et al.
Journal of Clinical Medicine|April 30, 2021
Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic ReviewMarion Bareille, Michaël Hardy, Jonathan Douxfils, et al.
Thrombosis and Haemostasis|December 19, 2014
Estimation of dabigatran plasma concentrations in the perioperative setting. An ex vivo study using dedicated coagulation assaysJonathan Douxfils, Sarah Lessire, Anne-Sophie Dincq, et al.
Thrombosis Research|March 14, 2024
Asundexian in atrial fibrillation: Can pharmacodynamic data explain the failure?Julie Vassart, Marie Didembourg, Laure Morimont, et al.
Viruses|August 10, 2021
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2Julien Favresse, Constant Gillot, Laura Di Chiaro, et al.
Medicine|July 7, 2019
Prospective and comparative study of paroxysmal nocturnal hemoglobinuria patients treated or not by eculizumab: Focus on platelet extracellular vesiclesBérangère Devalet, Adeline Wannez, Nicolas Bailly, et al.
Thrombosis Research|March 7, 2015
Does the Russell Viper Venom time test provide a rapid estimation of the intensity of oral anticoagulation? A cohort studyJonathan Douxfils, Bernard Chatelain, Paul Hjemdahl, et al.
Thrombosis Journal|November 21, 2018
Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective studyAnne-Laure Sennesael, Anne-Sophie Larock, Jonathan Douxfils, et al.
Pageof 23

Showing results (161-170 of 221) with videos related to

Sort By:
Pageof 23
Clinical Biochemistry|August 29, 2020
High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodiesAntoine Mairesse, Julien Favresse, Christine Eucher, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Evaluation of the DOAC-Stop® Procedure to Overcome the Effect of DOACs on Several Thrombophilia Screening TestsJulien Favresse, Benjamin Lardinois, Lina Sabor, et al.
Annales De Biologie Clinique|October 7, 2020
[Management of the thrombotic risk associated with COVID-19: what is the role of the hemostasis laboratory?]Michael Hardy, Jonathan Douxfils, Jean-Michel Dogné, et al.
Journal of Clinical Medicine|April 30, 2021
Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic ReviewMarion Bareille, Michaël Hardy, Jonathan Douxfils, et al.
Thrombosis and Haemostasis|December 19, 2014
Estimation of dabigatran plasma concentrations in the perioperative setting. An ex vivo study using dedicated coagulation assaysJonathan Douxfils, Sarah Lessire, Anne-Sophie Dincq, et al.
Thrombosis Research|March 14, 2024
Asundexian in atrial fibrillation: Can pharmacodynamic data explain the failure?Julie Vassart, Marie Didembourg, Laure Morimont, et al.
Viruses|August 10, 2021
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2Julien Favresse, Constant Gillot, Laura Di Chiaro, et al.
Medicine|July 7, 2019
Prospective and comparative study of paroxysmal nocturnal hemoglobinuria patients treated or not by eculizumab: Focus on platelet extracellular vesiclesBérangère Devalet, Adeline Wannez, Nicolas Bailly, et al.
Thrombosis Research|March 7, 2015
Does the Russell Viper Venom time test provide a rapid estimation of the intensity of oral anticoagulation? A cohort studyJonathan Douxfils, Bernard Chatelain, Paul Hjemdahl, et al.
Thrombosis Journal|November 21, 2018
Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective studyAnne-Laure Sennesael, Anne-Sophie Larock, Jonathan Douxfils, et al.
Pageof 23